These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30616014)

  • 1. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
    Huttner BD; de Lastours V; Wassenberg M; Maharshak N; Mauris A; Galperine T; Zanichelli V; Kapel N; Bellanger A; Olearo F; Duval X; Armand-Lefevre L; Carmeli Y; Bonten M; Fantin B; Harbarth S;
    Clin Microbiol Infect; 2019 Jul; 25(7):830-838. PubMed ID: 30616014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
    Huttner B; Haustein T; Uçkay I; Renzi G; Stewardson A; Schaerrer D; Agostinho A; Andremont A; Schrenzel J; Pittet D; Harbarth S
    J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the eradication of extended-spectrum beta-lactamase or carbapenemase-producing Enterobacteriaceae intestinal carriage.
    Catho G; Huttner BD
    Expert Rev Anti Infect Ther; 2019 Aug; 17(8):557-569. PubMed ID: 31313610
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.
    van den Bunt G; van Pelt W; Hidalgo L; Scharringa J; de Greeff SC; Schürch AC; Mughini-Gras L; Bonten MJM; Fluit AC
    Euro Surveill; 2019 Oct; 24(41):. PubMed ID: 31615600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis.
    Zhang HJ; Wang HW; Tian FY; Yang CZ; Zhao M; Ding YX; Wang XY; Cui XY
    Sci Rep; 2024 Oct; 14(1):24349. PubMed ID: 39420082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal decolonization of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature.
    Rieg S; Küpper MF; de With K; Serr A; Bohnert JA; Kern WV
    BMC Infect Dis; 2015 Oct; 15():475. PubMed ID: 26511929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial diversity and specific taxa are associated with decolonization of carbapenemase-producing enterobacterales after fecal microbiota transplantation.
    Davido B; Watson AR; de Truchis P; Galazzo G; Dinh A; Batista R; Terveer EM; Lawrence C; Michelon H; Jobard M; Saleh-Mghir A; Kuijper EJ; Caballero S
    J Infect; 2024 Aug; 89(2):106216. PubMed ID: 38964511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective.
    Bar-Yoseph H; Carasso S; Shklar S; Korytny A; Even Dar R; Daoud H; Nassar R; Maharshak N; Hussein K; Geffen Y; Chowers Y; Geva-Zatorsky N; Paul M
    Clin Infect Dis; 2021 Jul; 73(1):e166-e175. PubMed ID: 32511695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicentre, randomized, controlled, open-label, parallel-group clinical trial.
    Fariñas MC; González-Rico C; Fernández-Martínez M; Fortún J; Escudero-Sanchez R; Moreno A; Bodro M; Muñoz P; Valerio M; Montejo M; Nieto J; Ruiz-San Millan JC; Casafont-Morencos F; Martinez-Martínez L; Fariñas-Álvarez C;
    Clin Microbiol Infect; 2021 Jun; 27(6):856-863. PubMed ID: 33359562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial.
    Leo S; Lazarevic V; Girard M; Gaïa N; Schrenzel J; de Lastours V; Fantin B; Bonten M; Carmeli Y; Rondinaud E; Harbarth S; Huttner BD
    Microorganisms; 2020 Jun; 8(6):. PubMed ID: 32585945
    [No Abstract]   [Full Text] [Related]  

  • 11. Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.
    Saïdani N; Lagier JC; Cassir N; Million M; Baron S; Dubourg G; Eldin C; Kerbaj J; Valles C; Raoult D; Brouqui P
    Int J Antimicrob Agents; 2019 Apr; 53(4):355-361. PubMed ID: 30472293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study.
    Dinh A; Fessi H; Duran C; Batista R; Michelon H; Bouchand F; Lepeule R; Vittecoq D; Escaut L; Sobhani I; Lawrence C; Chast F; Ronco P; Davido B
    J Hosp Infect; 2018 Aug; 99(4):481-486. PubMed ID: 29477634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
    Bar-Yoseph H; Hussein K; Braun E; Paul M
    J Antimicrob Chemother; 2016 Oct; 71(10):2729-39. PubMed ID: 27317444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands.
    van Dulm E; Tholen ATR; Pettersson A; van Rooijen MS; Willemsen I; Molenaar P; Damen M; Gruteke P; Oostvogel P; Kuijper EJ; Hertogh CMPM; Vandenbroucke-Grauls CMJE; Scholing M
    PLoS One; 2019; 14(9):e0222200. PubMed ID: 31513682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics for intestinal decolonization of ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled clinical trial.
    Ljungquist O; Kampmann C; Resman F; Riesbeck K; Tham J
    Clin Microbiol Infect; 2020 Apr; 26(4):456-462. PubMed ID: 31494254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Faecal Carriage of ESBL-Producing Enterobacteriaceae among Children in Dar es Salaam, Tanzania.
    Tellevik MG; Blomberg B; Kommedal Ø; Maselle SY; Langeland N; Moyo SJ
    PLoS One; 2016; 11(12):e0168024. PubMed ID: 27936054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
    Ríos E; López MC; Rodríguez-Avial I; Culebras E; Picazo JJ
    J Med Microbiol; 2017 Feb; 66(2):169-174. PubMed ID: 27902381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR).
    Dimitriou V; Biehl LM; Hamprecht A; Vogel W; Dörfel D; Peter S; Schafhausen P; Rohde H; von Lilienfeld-Toal M; Klassert TE; Slickers P; Ehricht R; Slevogt H; Christ H; Hellmich M; Farowski F; Tsakmaklis A; Higgins PG; Seifert H; Vehreschild MJGT
    J Antimicrob Chemother; 2019 Jul; 74(7):2065-2074. PubMed ID: 31220256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of extended-spectrum β-lactamase (ESBL) and/or carbapenemase producing Enterobacteriaceae (CPE) and their antimicrobial resistance.
    Koren J; Hubenakova Z; Drahovska H; Ozaee E; Markuskova B; Lichvarikova A
    Bratisl Lek Listy; 2019; 120(12):935-940. PubMed ID: 31855054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.